Robert (Bob) Anderson, BMedSc, MB, ChB, PhD, FRACP
Chief Scientific Officer

Dr. Anderson is the inventor of ImmusanT’s technology in celiac disease and has led its development since 1999. Dr. Anderson is an internationally recognized leader in celiac disease. In 2005, Dr. Anderson co-founded ImmusanT’s immediate predecessor, Nexpep Pty Ltd. where he served multiple roles between 2005 and 2011. Prior to relocating to the United States in 2012 as Chief Scientific Officer of ImmusanT, Dr. Anderson was a Laboratory Head at the Walter and Eliza Hall Institute, and the gastroenterologist in charge of the Celiac Disease Clinic at the Alfred Hospital in Melbourne, Australia. His academic research was dedicated to understanding the immunology of celiac disease and defining the disease-causing components of gluten. He received grant support from the Australian NHMRC and CoeliacUK. During the time he was in Australia from 2002, Dr. Anderson initiated highly successful medical awareness programs to improve standards of care in celiac disease, founded the Australia New Zealand Coeliac Research Fund in conjunction with national patient support groups, and established dedicated clinics for celiac disease in the Departments of Gastroenterology at The Royal Melbourne Hospital and Alfred Hospital.

Dr. Anderson was awarded a Robert Menzies NHMRC travelling post-doctoral fellowship in 1997, and was based at the University of Oxford in the Nuffield Department of Medicine from 1998 to 2002. During this time, his research focus shifted from inflammatory bowel disease to celiac disease, and in patient-based studies he showed that short-term gluten challenge mobilized gluten-reactive T cells, allowing blood to be used as the source of T cells to define the immuno-dominant gluten peptide in celiac disease.

Dr. Anderson is a Fellow of the Royal Australasian College of Physicians specializing in adult internal medicine and gastroenterology, and a Fellow of the American Gastroenterological Association. Dr. Anderson attended medical school at the University of Otago in Dunedin, New Zealand. He holds degrees in medicine (M.B. Ch.B.), and medical science (B.Med.Sc.), and a doctorate in experimental medicine in the field of innate immunity and digestive disease, all from the University of Otago. His postgraduate clinical training in internal medicine and gastroenterology was at The Royal Melbourne Hospital, and St Vincent’s Hospital in Melbourne, Australia.